Formosa Laboratories, Inc.

Taiwan Stock Exchange 4746.TW

Formosa Laboratories, Inc. Return on Assets (ROA) for the year ending December 31, 2023: 0.93%

Formosa Laboratories, Inc. Return on Assets (ROA) is 0.93% for the year ending December 31, 2023, a -45.55% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Formosa Laboratories, Inc. Return on Assets (ROA) for the year ending December 31, 2022 was 1.70%, a -83.64% change year over year.
Formosa Laboratories, Inc. Return on Assets (ROA) for the year ending December 31, 2021 was 10.39%, a 167.26% change year over year.
Formosa Laboratories, Inc. Return on Assets (ROA) for the year ending December 31, 2020 was 3.89%, a 1,010.06% change year over year.
Formosa Laboratories, Inc. Return on Assets (ROA) for the year ending December 31, 2019 was -0.43%, a -121.09% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Taiwan Stock Exchange: 4746.TW

Formosa Laboratories, Inc.

CEO	Dr. Chen-Yu Cheng Ph.D.
IPO Date	Feb. 28, 2011
Location	Taiwan
Headquarters	36 Hoping Street
Employees	867
Sector	Health Care
Industries Pharmaceuticals

Description

Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.

Key trends

Past 5 years